KRAS and neoplasm: Similarly, organoid-immune co-cultures integrating patient-derived tumor cells, tumor-infiltrating lymphocytes, and PBMCs could elucidate the mechanism underlying immune-stromal crosstalk modulating KRAS G12Ci responses, though this remains under-explored in lung cancer.145